Provided by Tiger Trade Technology Pte. Ltd.

GENSCRIPT BIO

10.750
-0.260-2.36%
Volume:4.68M
Turnover:50.68M
Market Cap:23.51B
PE:-5.59
High:11.200
Open:11.010
Low:10.660
Close:11.010
52wk High:19.400
52wk Low:9.450
Shares:2.19B
HK Float Shares:2.19B
Volume Ratio:0.60
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.923
ROE:-12.85%
ROA:3.15%
PB:0.76
PE(LYR):-5.59
PS:3.13

Loading ...

GenScript Biotech Files HKEX Return for 13,142 New Shares Issued at HKD 0.00778 Each

Reuters
·
Nov 20, 2025

Why Genscript Biotech (SEHK:1548) Is Up 8.0% After Legend Biotech’s CARVYKTI Drives Smaller Q3 Loss

Simply Wall St.
·
Nov 15, 2025

Genscript Biotech (SEHK:1548): Reviewing Valuation After Analyst and Investor Day Update

Simply Wall St.
·
Nov 13, 2025

HK Stock Movement | GENSCRIPT BIO (01548) Drops Over 4% as Associate Legend Biotech Reports Narrowed Q3 Net Loss of $39.7M

Stock News
·
Nov 13, 2025

GenScript Biotech Affiliate Legend Biotech Reports Q3 2025 Financial Results

Reuters
·
Nov 12, 2025

Legend Biotech Q3 revenue slightly misses estimates

Reuters
·
Nov 12, 2025

Cabaletta Bio Appoints Steve Gavel as Chief Commercial Officer

Reuters
·
Nov 10, 2025

Genscript Biotech (01548) Announces Monthly Return for October 2025, Issued Shares Reach 2,185,678,939

Bulletin Express
·
Nov 04, 2025

GENSCRIPT BIO (01548): Legend Biotech to Present Latest Data at ASH Annual Meeting

Stock News
·
Nov 04, 2025

Genscript Biotech Corporation (1548) Announces Legend Biotech’s Data Presentation at 2025 ASH Meeting

Bulletin Express
·
Nov 04, 2025

Legend Biotech Unveils New CAR-T and Allogeneic Cell Therapy Data at ASH 2025

Reuters
·
Nov 04, 2025

Legend Biotech Corporation to Announce Third Quarter 2025 Results

Reuters
·
Oct 29, 2025

GENSCRIPT BIO (01548): CARVYKTI® Generates Net Trade Sales of Approximately $524 Million for Quarter Ended September 30, 2025

Stock News
·
Oct 14, 2025

Legend Biotech Announces FDA Approval of CARVYKTI® Label Update to Include Overall Survival Data and New Safety Warnings

Reuters
·
Oct 14, 2025

Legend Biotech Reports Preliminary CARVYKTI® Net Trade Sales of $524 Million for Q3 2025

Reuters
·
Oct 14, 2025

GENSCRIPT BIO (01548): Subsidiary Receives New Payment Under License Agreement with LM Pharma

Stock News
·
Oct 14, 2025

GenScript Biotech announces payment received under license agreement with LaNova Medicines

Reuters
·
Oct 14, 2025

Is Genscript Biotech Corporation (HKG:1548) Trading At A 44% Discount?

Simply Wall St.
·
Oct 11, 2025

US FDA adds boxed warning to J&J, Legend Biotech's cancer therapy

Reuters
·
Oct 11, 2025

Legend Biotech Signs Component and Product Supply Agreement with Janssen Pharmaceuticals for Cilta cel Manufacturing

Reuters
·
Oct 08, 2025